Raymond James Financial Services Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,635
Closed -$242K 3330
2021
Q1
$242K Buy
8,635
+715
+9% +$21.1K ﹤0.01% 2777
2020
Q4
$206K Hold
7,920
﹤0.01% 2697
2020
Q3
$294K Sell
7,920
-5,850
-42% -$232K ﹤0.01% 2297
2020
Q2
$707K Sell
13,770
-2,022
-13% -$84.6K ﹤0.01% 1699
2020
Q1
$498K Buy
15,792
+3,131
+25% +$165K ﹤0.01% 1559
2019
Q4
$755K Buy
12,661
+200
+2% +$8.99K ﹤0.01% 1709
2019
Q3
$457K Sell
12,461
-173
-1% -$6.85K ﹤0.01% 1956
2019
Q2
$588K Sell
12,634
-196
-2% -$9.21K ﹤0.01% 1818
2019
Q1
$515K Sell
12,830
-490
-4% -$22K ﹤0.01% 1886
2018
Q4
$613K Buy
+13,320
New +$642K ﹤0.01% 1535
2018
Q2
Sell
-3,870
Closed -$280K 2804
2018
Q1
$280K Buy
3,870
+505
+15% +$37.1K ﹤0.01% 2072
2017
Q4
$222K Buy
+3,365
New +$181K ﹤0.01% 2190

Other funds holding ESPR